A multi centre study to determine the efficacy and patient acceptability of scalp cooling in the prevention of docetaxel-induced hair loss.
Completed
- Conditions
- Hair loss
- Registration Number
- NL-OMON26657
- Lead Sponsor
- eids Universitair Medisch Centrum in Leiden
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 260
Inclusion Criteria
1. Intravenous administered docetaxel regimes;
2. Age 18 years or more;
Exclusion Criteria
1. Boldness before the start of the study;
2. Heamatological malignancies with generalized haematogenic metastases (e.g. lymphoma, leukemia and multiple myeloma) and if in those conditions chemotherapy is given with a curative intent;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy and patient acceptability of scalp cooling.
- Secondary Outcome Measures
Name Time Method Relation of the efficacy of scalp cooling and:<br /><br>1. prior treatment with cytostatic agents;<br /><br>2. prior or parallel hormonal treatment;<br /><br>3. prior radiotherapy of the scalp;<br /><br>4. liver metastases and/ or liver or kidney function disorder;<br /><br>4. type of hair (determined by race).